Loading…
Lobbying Spend
—
Filings
67
Firms Hired
3
Active Period
2001–2017
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases Advocated for support of House Dear Colleague Letter asking for signatures for additional NIH Funding Opposed H.R. 3699, which prohibits a federal agency from adopting, maintaining, continuing, or otherwise engaging in any policy, program, or other activity that: (1)causes, permits, or authorizes network dissemination of any private-sector research work without the prior consent of the publisher; or (2) requires that any actual or prospective author, or the author's employer, assent to such network dissemination.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3699
Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases Advocated for support of House Dear Colleague Letter asking for signatures for additional NIH Funding Opposed H.R. 3699, which prohibits a federal agency from adopting, maintaining, continuing, or otherwise engaging in any policy, program, or other activity that: (1)causes, permits, or authorizes network dissemination of any private-sector research work without the prior consent of the publisher; or (2) requires that any actual or prospective author, or the author's employer, assent to such network dissemination. Organized Fred Hutchinson Cancer Research Center (FHCRC) event demonstrating the importance of the work FHCRC is doing in Washington State and the region
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3699
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
2010 · fourth_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocated in support of the 21st Century Cancer ALERT Act (S. 717), the Stem Cell Research Advancement Act, and the Cancer Center Assistance for Renocation and Expansion Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 717
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
2010 · fourth_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocated in support of the 21st Century Cancer ALERT Act (S. 717), the Stem Cell Research Advancement Act, and the Cancer Center Assistance for Renocation and Expansion Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 717
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
2010 · third_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocated in support of the 21st Century Cancer ALERT Act (S. 717).
Client expense: — · Firm income: $30,000
Matched citations: S. 717
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
2010 · third_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocated in support of the 21st Century Cancer ALERT Act (S. 717).
Client expense: — · Firm income: $30,000
Matched citations: S. 717
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
2010 · second_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocated in support of the 21st Century Cancer ALERT Act (S. 717).
Client expense: — · Firm income: $30,000
Matched citations: S. 717
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
2010 · second_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocated in support of the 21st Century Cancer ALERT Act (S. 717).
Client expense: — · Firm income: $30,000
Matched citations: S. 717
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
2010 · first_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocated in support of the 21st Century Cancer ALERT Act (S. 717) (Access to Life-saving Early Detection, Research and Treatment). Support funding for the Federal Coordinating Council on Comparative Effectiveness Research (CER) and urge Congress to provide the Agency for Healthcare Research and Quality with the full $286 million requested by the President.
Client expense: — · Firm income: $30,000
Matched citations: S. 717
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
2010 · first_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocated in support of the 21st Century Cancer ALERT Act (S. 717) (Access to Life-saving Early Detection, Research and Treatment). Support funding for the Federal Coordinating Council on Comparative Effectiveness Research (CER) and urge Congress to provide the Agency for Healthcare Research and Quality with the full $286 million requested by the President.). Support amendment to health reform bill that would require coverage of routine patients costs associated with clinical trial participation.
Client expense: — · Firm income: $30,000
Matched citations: S. 717
Colorectal Cancer Prevention, Early Detection, and Treatment Act of 2009
2009 · fourth_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: HR 1189, the Colorectal Cancer Early Detection, prevention and Treatment Act; HR 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S 332 the Lung Cancer Mortality reduction Act of 2009.
Client expense: — · Firm income: $30,000
Matched citations: HR 1189
Colorectal Cancer Prevention, Early Detection, and Treatment Act of 2009
2009 · fourth_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: HR 1189, the Colorectal Cancer Early Detection, prevention and Treatment Act; HR 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S 332 the Lung Cancer Mortality Reduction Act of 2009. Advocate proposal for training the next generation of physician-scientists in translational medicine.
Client expense: — · Firm income: $30,000
Matched citations: HR 1189
Medicare Early Detection of Cancer Promotion Act of 2009
2009 · fourth_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: HR 1189, the Colorectal Cancer Early Detection, prevention and Treatment Act; HR 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S 332 the Lung Cancer Mortality reduction Act of 2009.
Client expense: — · Firm income: $30,000
Matched citations: HR 2291
Medicare Early Detection of Cancer Promotion Act of 2009
2009 · fourth_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: HR 1189, the Colorectal Cancer Early Detection, prevention and Treatment Act; HR 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S 332 the Lung Cancer Mortality Reduction Act of 2009. Advocate proposal for training the next generation of physician-scientists in translational medicine.
Client expense: — · Firm income: $30,000
Matched citations: HR 2291
Lung Cancer Mortality Reduction Act of 2009
2009 · fourth_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: HR 1189, the Colorectal Cancer Early Detection, prevention and Treatment Act; HR 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S 332 the Lung Cancer Mortality reduction Act of 2009.
Client expense: — · Firm income: $30,000
Matched citations: S 332
Lung Cancer Mortality Reduction Act of 2009
2009 · fourth_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: HR 1189, the Colorectal Cancer Early Detection, prevention and Treatment Act; HR 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S 332 the Lung Cancer Mortality Reduction Act of 2009. Advocate proposal for training the next generation of physician-scientists in translational medicine.
Client expense: — · Firm income: $30,000
Matched citations: S 332
Colorectal Cancer Prevention, Early Detection, and Treatment Act of 2009
2009 · third_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act; H.R. 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S. 332 the Lung Cancer Mortality Reduction Act of 2009. Advocate proposal for training the next generation of physician-scientists in translational medicine.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1189
Colorectal Cancer Prevention, Early Detection, and Treatment Act of 2009
2009 · third_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act; H.R. 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S. 332 the Lung Cancer Mortality Reduction Act of 2009.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1189
Medicare Early Detection of Cancer Promotion Act of 2009
2009 · third_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act; H.R. 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S. 332 the Lung Cancer Mortality Reduction Act of 2009. Advocate proposal for training the next generation of physician-scientists in translational medicine.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2291
Medicare Early Detection of Cancer Promotion Act of 2009
2009 · third_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act; H.R. 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S. 332 the Lung Cancer Mortality Reduction Act of 2009.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2291
Lung Cancer Mortality Reduction Act of 2009
2009 · third_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act; H.R. 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S. 332 the Lung Cancer Mortality Reduction Act of 2009. Advocate proposal for training the next generation of physician-scientists in translational medicine.
Client expense: — · Firm income: $30,000
Matched citations: S. 332
Lung Cancer Mortality Reduction Act of 2009
2009 · third_quarter · Firm: THE PETRIZZO GROUP, INC.
Advocate for the following bills: H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act; H.R. 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S. 332 the Lung Cancer Mortality Reduction Act of 2009.
Client expense: — · Firm income: $30,000
Matched citations: S. 332
Colorectal Cancer Prevention, Early Detection, and Treatment Act of 2009
2009 · second_quarter · Firm: THE PETRIZZO GROUP, INC.
Advance legislation and/or Executive branch declaration to provide liability protection to entities administering the Global HVTN Clinical Trial on behalf of NIH. Support H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act. In support of nomination of Dr. Lee Hartwell to President's Council on Science & Technology. In support of H.R. 2291 to eliminate coinsurance for screening mammagraphy and colorectal cancer screening tests.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1189
Colorectal Cancer Prevention, Early Detection, and Treatment Act of 2009
2009 · second_quarter · Firm: THE PETRIZZO GROUP, INC.
Advance legislation and/or Executive branch declaration to provide liability protection to entities administering the Global HVTN Clinical Trial on behalf of NIH. Support H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act. Support increased funding of NIH and NCI.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1189
Medicare Early Detection of Cancer Promotion Act of 2009
2009 · second_quarter · Firm: THE PETRIZZO GROUP, INC.
Advance legislation and/or Executive branch declaration to provide liability protection to entities administering the Global HVTN Clinical Trial on behalf of NIH. Support H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act. In support of nomination of Dr. Lee Hartwell to President's Council on Science & Technology. In support of H.R. 2291 to eliminate coinsurance for screening mammagraphy and colorectal cancer screening tests.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2291
Source: Senate LDA